Mr. Daniel Suer
CEO
ShangRao Chunyu Technology Co., Ltd.
Xuri Zone
Shangrao Economic-Technical Development Area
Shangrao Shi
Jiangxi Sheng , 334100
ChinaFEI 3015958566Issued Feb 3, 2021Center for Drug Evaluation and Research | CDER
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3015958566.
Violations2
Issue DateFeb 3, 2021
Product TypeDrugs
StatusOpen
Letter Details
Firm
ShangRao Chunyu Technology Co., Ltd.
Location
Mr. Daniel Suer
CEO
ShangRao Chunyu Technology Co., Ltd.
Xuri Zone
Shangrao Economic-Technical Development Area
Shangrao Shi
Jiangxi Sheng , 334100
China
FEI Number
3015958566
Country
China
Issue Date
February 03, 2021
Issuing Office
Center for Drug Evaluation and Research | CDER
Product Type
Drugs
Status
Open
Summary
ShangRao Chunyu Technology Co., Ltd. manufactured an antiseptic hand sanitizer product labeled as containing 75% ethanol that was found to contain only 58% ethanol when tested by FDA at the U.S. border. The subpotent product violated Current Good Manufacturing Practice (CGMP) requirements, demonstrating that the company's quality assurance procedures were not functioning adequately to ensure the strength, purity, and quality of finished pharmaceuticals. The batch was detained and refused admission into the United States due to these adulteration violations under sections 501(a)(2)(B) and 501(c) of the Federal Food, Drug, and Cosmetic Act.
ShangRao Chunyu Technology Co., Ltd. FDA Warning Letter, February 3, 2021